Proteome Sciences plc Stock OTC Markets
Stocks
PMSNF
GB0003104196
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0248 USD | -35.29% |
|
-.--% | -35.25% |
| 06-23 | WINNERS & LOSERS: Ramsdens accepts GBP206 million Firstcash offer | AN |
| 06-22 | FTSE 100 in green, UK prime minister resigns | AN |
| Market Cap | 5.26M 6.94M 6.1M 5.62M 9.86M 658M 10.02M 67.48M 26.12M 323M 26.06M 25.5M 1.12B | P/E 2024 |
-2.95x | P/E 2025 | -2.4x |
|---|---|---|---|---|---|
| Enterprise Value | 20.25M 26.72M 23.48M 21.63M 37.94M 2.53B 38.58M 260M 101M 1.24B 100M 98.16M 4.32B | EV / Sales 2024 |
4.79x | EV / Sales 2025 | 5.96x |
| Free-Float |
81.91% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -35.29% | ||
| 3 months | -35.25% | ||
| 6 months | -35.25% | ||
| Current year | -35.25% |
| Current year | 0.02 | 0.02 | |
| 1 year | 0.01 | 0.05 | |
| 3 years | 0.01 | 0.09 | |
| 5 years | 0.01 | 0.18 | |
| 10 years | 0.01 | 0.23 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Dennis
PRN | Corporate Officer/Principal | - | 2017-03-31 |
Victoria Birse
SEC | Corporate Secretary | - | 2017-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 2014-06-29 | |
Ian Pike
BRD | Director/Board Member | 62 | 2009-12-31 |
Roger McDowell
BRD | Director/Board Member | 71 | 2014-06-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -35.29% | -.--% | - | - | 6.97M | ||
| +3.07% | -0.10% | -32.07% | -16.21% | 153B | ||
| +1.72% | -0.85% | -6.20% | -7.83% | 101B | ||
| -1.25% | -5.30% | +52.06% | +56.48% | 55.9B | ||
| +3.62% | -0.13% | -4.10% | +49.78% | 52.78B | ||
| +2.28% | -0.85% | -15.20% | -43.90% | 38.77B | ||
| +1.70% | -4.83% | - | - | 29.35B | ||
| -0.22% | -5.80% | -13.68% | -45.63% | 26.65B | ||
| +2.03% | +2.07% | +55.23% | -8.34% | 23.29B | ||
| -0.57% | -2.87% | -18.62% | -4.09% | 20.51B | ||
| Average | -2.29% | -1.66% | +2.18% | -2.47% | 55.75B | |
| Weighted average by Cap. | +1.86% | -1.10% | -6.12% | -1.45% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.89M 6.45M 5.67M 5.22M 9.16M 611M 9.31M 62.68M 24.26M 300M 24.21M 23.69M 1.04B | 3.76M 4.96M 4.35M 4.01M 7.04M 470M 7.16M 48.18M 18.65M 230M 18.61M 18.21M 801M |
| Net income | -3.41M -4.49M -3.95M -3.64M -6.38M -426M -6.49M -43.69M -16.91M -209M -16.87M -16.51M -726M | -3.06M -4.04M -3.55M -3.27M -5.74M -383M -5.83M -39.26M -15.2M -188M -15.16M -14.84M -653M |
| Net Debt | 13.39M 17.68M 15.53M 14.31M 25.09M 1.67B 25.52M 172M 66.5M 822M 66.35M 64.92M 2.86B | 14.99M 19.78M 17.38M 16.01M 28.08M 1.87B 28.56M 192M 74.42M 919M 74.25M 72.66M 3.2B |
Employees
32
- Stock Market
- Stocks
- PRM Stock
- PMSNF Stock
Select your edition
All financial news and data tailored to specific country editions
















